Skip to main content
SpringerLink
Log in

Sklerosierungstherapie der Varikose

Sclerotherapy for varicosities

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Die Sklerosierungstherapie hat ihren festen Stellenwert in der Behandlung von retikulären Varizen und Seitenästen. Bei der Stammvarikose galt in der Vergangenheit die Operation als Methode der ersten Wahl. In letzter Zeit haben auch endovenöse Verfahren wie die endovenöse Lasertherapie und die Radiofrequenzmethode gute Ergebnisse erzielt. Durch die Einführung der Sklerosierung mit aufgeschäumten Verödungsmitteln konnte auch die Effektivität der Sklerosierung bei großen Varizen und der Stammvarikose deutlich gesteigert werden. Dieses ambulante Verfahren, das keine Anästhesie benötigt, zeigt eine sehr gute Kosten-Nutzen-Relation. Randomisierte Vergleichsstudien zu den operativen Verfahren stehen aber noch aus.

Abstract

Sclerotherapy is a standard treatment for intradermal varicose veins and branch varicosities. In the treatment of insufficient saphenous veins, crossectomy and stripping used to be the methods of choice. In the last few years good results have also been reported for endovenous methods such as endovenous laser and radio frequency treatment. Sclerotherapy is more effective and even appropriate for larger saphenous veins when the sclerosing liquid is replaced by a foam agent. This cost-effective approach can be done on an outpatient basis without additional anesthesia. Prospective randomized studies are need to confirm the effectiveness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Baccaglini U, Spreafico G, Castoro C, Sorrentino P (1997) Consensus Conference on Sclerotherapy or Varicose Veins of the Lower Limbs. Phlebology 12:2–16

    Google Scholar 

  2. Baccaglini U, Stemmer R, Partsch U (1997) Internationale Fragebogenaktion zur Praxis der Verödungsbehandlung. Phlebologie 26:129–142

    Google Scholar 

  3. Barrett JM, Allen B, Ockelford A, Goldmann M (2004) Microfoam ultrasound — guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 30:6–12

    Article  PubMed  Google Scholar 

  4. Benigni JP, Sadoun S, Thirion V et al. (1999) Télangictasies et varices réticulaires Traitement par la mousse d’Aetoxisclérol á 0,25%. Présentation d’une étude pilote. Phlébologie 52(3):283–290

    Google Scholar 

  5. Bergan JJ, Weiss RA, Goldman MP (2000) Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 26:535–542

    Article  PubMed  Google Scholar 

  6. Breu FX, Guggenbichler S (2004) European Consensus Meeting on Foam Sclerotherapy, April 4–6 2003, Tegernsee, Germany. Dermatol Surg 30:709–717

    Article  PubMed  Google Scholar 

  7. Cavezzi A, Frullini A (1998) Echosclerotherapy in the short saphenous vein insufficiency: personal experience. Abstract UIP, Sydney

    Google Scholar 

  8. Cavezzi A, Frullini A (1998) Il ruola della mousse sclerosante nella ecosclerosi safenica e delle varici recidive. Esperienza personale. Flebologia 9:1–3

    Google Scholar 

  9. Conrad P, Malouf GM, Stacey MC (1994) The Australian Polidocanol (Aethoxysklerol) Study. Results at 1 year. Phlebology 9:17–20

    Google Scholar 

  10. Conrad P, Malouf GM, Stacey MC (1995) The Australian Polidocanol (Aethoxysklerol) study. Results at 2 years. Dermatol Surg 21:334–336

    Article  PubMed  Google Scholar 

  11. Drake LA, Dinehart SM, Goltz RW et al. (1996) Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins. J Am Acad Dermatol 34:523–528

    Article  PubMed  Google Scholar 

  12. Dover J, N Sadick, MP Goldman (1999) The role of lasers and light sources in the treatment of leg veins. Derm Surg 25:328–336

    Article  Google Scholar 

  13. Einarsson E, Eklöf B, Neglén P (1993) Sclerotherapy or surgery as treatment for varicose veins: a prospective randomized study. Phlebology 8:22–26

    Google Scholar 

  14. Fegan WG (1963) Continous compression technique of infecting varicose veins. Lancet 1963:109–112

    Article  Google Scholar 

  15. Feied CF (1993) Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states. Sem Dermatol 12(2):135–149

    Google Scholar 

  16. Feied CF, Jackson JJ, Bren TS et al. (1994) Allergic reactions to polidocanol for vein sclerosis. J Dermatol Surg Oncol 20:466–468

    PubMed  Google Scholar 

  17. Feuerstein W (1973) Schwere anaphylaktische Reaktion auf Hydroxypolyaethoxydodecan. VASA 3(2):292–294

    Google Scholar 

  18. Fisher DA (2000) Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 26(11):1081

    Article  PubMed  Google Scholar 

  19. Flückiger P (1956) Nicht-operative retrograde Varicenverödung mit Varisylschaum. Schweiz Med Wochenschr 48:1368–1370

    Google Scholar 

  20. Frullini A, Cavezzi A (1999) Ultrasound guided sclerotherapy in the treatment of long saphenaous vein insufficiency. Vasomed 11 [Suppl] 1:8

    Google Scholar 

  21. Frullini A (2002) Sclerosing foam in the treatment of recurrent varicose veins In: Henriet JP (ed) Foam sclerotherapy state of the art. Editions Phlebologiques Francaises 2002:73–78

    Google Scholar 

  22. Frullini A, Cavezzi A (2002) Sclerosing foam in the treatment of varicose veins and teleangiectases: history and analyses of safety and complications. Dermatol Surg 28:11–15

    Article  PubMed  Google Scholar 

  23. Frullini A (2000) New technique in producing sclerosing foam in a disposable syringe. Dermatol Surg 26:705–796

    Article  PubMed  Google Scholar 

  24. Georgiev M (1993) Postsclerotherapy hyperpigmentations. J Dermatol Surg Oncol 19:649–652

    PubMed  Google Scholar 

  25. Geukens J, Rabe E, Bieber T (1999) Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol 9:132–133

    PubMed  Google Scholar 

  26. Gobin JP (2001) The sclerotherapy position in recurrent varicose veins treatment. Int Angiology 20, 2, [Suppl 1], 336, 14. UIP’01, 09–14.09.2001, Rom

  27. Goldman PM (1989) Polidocanol (Aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias. J Dermatol Surg Oncol 15:204–209

    Google Scholar 

  28. Goldman PM, Beaudoing D, Marley W et al. (1990) Compression in the treatment of leg teleangiectasia: a preliminary report. J Dermatol Surg Oncol 16:322–325

    PubMed  Google Scholar 

  29. Goldman MP, Sadick NS, Weiss RA (1995) Cutaneous necrosis, telangiectatic matting and hyperpigmentation following sclerotherapy. Dermatol Surg 21:19–29

    PubMed  Google Scholar 

  30. Goldmann PM (1996) Complications of sclerotherapy. In: Gloviczki P, Yao J (eds) Handbook of venous disorders. Chapmann & Hall Medical, London, pp 374–93

  31. Grondin L, Young R, Wouters L (1997) Sclérothérapie ècho-guidée et sécurité: comparison des techniques. Phlebologie 50(2):241–245

    Google Scholar 

  32. Guex JJ (2000) Ultrasound guided sclerotherapy (USGS) for perforating veins. Hawaii Med J 59(6):261–262

    PubMed  Google Scholar 

  33. Guex JJ, Allaert FA, Gillet JL, Chleir F (2005) Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 31:123–128

    PubMed  Google Scholar 

  34. Härtel SL (1998) Fünf-Jahres Nachuntersuchungsergebnisse der Sklerosierungstherapie nach Stemmer bei 118 Patienten mit primärer Varikosis. Vasomed 4:272–273

    Google Scholar 

  35. Hamel-Desnos C, Desnos P, Ouvry P (2003) Nouveautés thérapeutiques dans la prise en charge de la maladie variqueuse: écho-sclérothérapie et mousse. Phlébologie 56(1):41

    Google Scholar 

  36. Hamel-Desnos C, Desnos P, Wollmann JC et al. (2003) Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 29:1170–1175

    PubMed  Google Scholar 

  37. Henriet JP (1997) One year experience with sclerotherapy of reticular veins and telangiectases using polidocanol foam in daily routine: feasibility results, complications. Phlébologie 50(3):355–360

    Google Scholar 

  38. Hohlbaum G (1990) Über iatrogene Schäden bei der Varizensklerosierung. In: Staubesand J, Schöpf E (Hrsg) Neuere Aspekte der Sklerosierungstherapie. Springer, Berlin Heidelberg New York Tokyo, S 70–81

  39. Hübner K (1991) Ambulante Therapie der Stammvarikose mittels Krossektomie und Sklerotherapie — ein Beitrag aus der Praxis des niedergelassenen Phlebologen. Phlebologie 20:104–108

    Google Scholar 

  40. Kern P, Ramelet AA, Wutschert R et al. (2004) Single-blind, randomized study comparing chromated glycerin, polidocanol solution and polidocanol foam for treatment teleangiectatic leg veins. Dermatol Surg 30:367–372

    PubMed  Google Scholar 

  41. Kersting E, Hornschuh B, Bröcker EB (1998) Embolia cutis medicamentosa nach Varizensklerosierung mit Polidocanol. Phlebologie 27:55–57

    Google Scholar 

  42. Kreussler (1996) Aethoxysklerol-Fachinformation der Herstellerfirma, Chemische Fabrik Kreussler & Co GmbH, Stand 2/1996

  43. Malouf GM (2000) Ambulatory venous surgery versus sclerotherapy. Hawaii Med J 59:248–249

    PubMed  Google Scholar 

  44. Massay RA (1999) Regarding the use of compression stockings after sclerotherapy. Dermatol Surg 25:517

    Article  Google Scholar 

  45. Mayer H, Brücke H (1957) Zur Ätiologie und Behandlung der Varizen der unteren Extremität. Chir Praxis 4:521–528

    Google Scholar 

  46. McCoy S, Evans A, Spurrier N (1999) Sclerotherapy for leg telangiectasia — a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 25:381–386

    Article  PubMed  Google Scholar 

  47. Mc Donagh B (1999) Comments on the use of post-sclerotherapy compression. Dermatol Surg 25(6):519–521

    Google Scholar 

  48. Monfreux A (1997) Traitement sclérosant des troncs saphèniens et leurs collatèrales de gros calibre par la méthode mus. Phlébologie 50(3):351–353

    Google Scholar 

  49. Norris MJ, Carlin MC, Ratz JL (1989) Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol. J Am Acad of Dermatol 20(4):643–649

    Google Scholar 

  50. Oesch A, Stirnemann P, Mahler F (1984) The acute ischemic syndrome of the foot after sclerotherapy of varicose veins. Schweiz Med Wochenschr 114:1155–1158

    PubMed  Google Scholar 

  51. Pradalier A, Vincent D, Hentschel V et al. (1995) Allergie aux sclérosants des varices. Rev Fr Allergol 35(5):440–443

    Google Scholar 

  52. Rabe E (2003) Grundlagen der Phlebologie, 3. Aufl. Viavital, Köln

  53. Rabe E, Pannier-Fischer F, Gerlach H et al. (2003) Leitlinien zur Sklerosierungsbehandlung der Varikose. Phlebologie 32:101–107

    Google Scholar 

  54. Rabe E, Pannier-Fischer F, Gerlach H et al. (2004) Guidelines for sclerotherapy of varicose veins. Dermatol Surg 30:687–693

    Article  PubMed  Google Scholar 

  55. Reddy P, Wickers J, Terry T et al. (1986) What is the correct period of bandaging following sclerotherapy? Phlebology 1986:217–220

    Google Scholar 

  56. Remy W, Vogt HJ, Borelli S (1978) Embolia cutis medicamentosa-artige Hautnekrosen nach Sklerosierungsbehandlung. Phlebol Proktol 7:67–72

    Google Scholar 

  57. Sadoun S, Benigni JP (1999) La mousse de sclerosant: etat de l’art. In: Rabe E et al. (eds) Phlebology ‚99. Viavital, Köln, p 146

  58. Seydewitz V, Staubesand J (1990) Das ultrastrukturelle Substrat der Wirkung paravasal und intraarteriell applizierter Sklerosierungsmittel: Ein experimenteller Beitrag zum Problem iatrogener Schäden nach Sklerotherapie. In: Staubesand J, Schöpf E (Hrsg) Neuere Aspekte der Sklerosierungstherapie. Springer, Berlin Heidelberg New York, S 40–65

  59. Sigg K (1949) Neuere Gesichtspunkte zur Technik der Varizenbehandlung. Ther Umschau 6:127–134

    Google Scholar 

  60. Schadeck M (1996) Duplex-kontrollierte Sklerosierungsbehandlung der V. saphena magna. Phlebologie 25:78–82

    Google Scholar 

  61. Schadeck M, Allaert FA (1997) Résultats à long terme de la Sclérothérapie des Saphènes internes. Phlebologie 50(2):257–262

    Google Scholar 

  62. Schadeck M (1999) Echo-sclerotherapy. Phlébologie 52 (Special Issue 10):103–106

  63. Schultz-Ehrenburg U, Tourbier H (1984) Doppler-kontrollierte Verödungsbehandlung der V. saphena magna. Phlebol Proktol 13:117–122

    Google Scholar 

  64. Stanley PRW, Bickerton DR, Campbell WB (1991) Injection sclerotherapy for varicose veins — a comparison of materials for applying local compression. Phlebology 1991:37–39

    Google Scholar 

  65. Tazelaar DJ, Neumann HAM, de Roos KP (1999) Long cotton wool rolls as compression enhancers in macrosclerotherapy for varicose veins. Dermatol Surg 25(1):38–40

    Article  PubMed  Google Scholar 

  66. Tessari L, Cavezzi A, Frullini A (2001) Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 27:58–60

    Article  PubMed  Google Scholar 

  67. Tessari L (2000) Nouvelle technique d’obtention de la sclèro-mousse. Phlébologie 53(1):129

    Google Scholar 

  68. Van Neer PAFA (2004) Perforans varicosis: treatment of incompetent perforating vein is important. Dermatol Surg 30:754–755

    Article  PubMed  Google Scholar 

  69. Van der Plas JPL, Lambers JC, van Wersch JW, Koehler PJ (1994) Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 343:428

    Google Scholar 

  70. Villavicencio J, Pfeifer J, Lohr J et al. (1996) Sclerotherapy for varicose veins: practice guidelines and sclerotherapy procedures. In: Glovicki P, Yao J (eds) Handbook of venous disorders. Chapmann & Hall Medical, London, pp 337–354

  71. Vin F (1997) Principes de la sclérothéraphie des troncs saphènes internes. Phlebologie 50(2):229–234

    Google Scholar 

  72. Weiss RA, Weiss MA (1990) Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonics saline vs. polidocanol. J Dermatol Surg Oncol 16:800–804

    PubMed  Google Scholar 

  73. Weiss RA, Sadick NS, Goldman MP, Weiss MA (1999) Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 25:105–108

    Article  PubMed  Google Scholar 

  74. Wenner L (1986) Improvement of immediate and long-term results in sclerotherapy. VASA 15:180–183

    PubMed  Google Scholar 

  75. Wollmann JC (2002) Schaum — zwischen Vergangenheit und Zukunft. 8. Bonner Venentage 2002 15.–16. Feb. Vasomed 16(1):34–38

    Google Scholar 

  76. Wollmann JC (2004) The history of sclerosing foams. Dermatol Surg 30:694–703

    Article  PubMed  Google Scholar 

  77. Yamaki T, Nozaki M, Sasaki K (2000) Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 26(4):323–328

    Article  PubMed  Google Scholar 

  78. Yamaki T, Nozaki M, Fujiwara O, Yoshida E (2002) Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face. Dermatol Surg 28(7):619–622

    Article  PubMed  Google Scholar 

  79. Yamaki T, Nozaki M, Iwasaka S (2004) Comparative study of duplex-guided foam sclerotherapy and duplex guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 30:718–722

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie der Rheinischen Friedrich-Wilhelms-Universität Bonn

    F. Pannier & E. Rabe

  2. Klinik und Poliklinik für Dermatologie der Rheinischen Friedrich-Wilhelms-Universität Bonn, Sigmund-Freud-Straße 25, 53105 , Bonn

    F. Pannier

Authors
  1. F. Pannier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Rabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Pannier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pannier, F., Rabe, E. Sklerosierungstherapie der Varikose. Hautarzt 57, 19–25 (2006). https://doi.org/10.1007/s00105-005-1072-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-005-1072-9

Schlüsselwörter

Keywords

Search

Navigation